<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
      <PMID Version="1">31655931</PMID>
      <DateCompleted>
        <Year>2020</Year>
        <Month>10</Month>
        <Day>05</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2021</Year>
        <Month>09</Month>
        <Day>07</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1435-4373</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>39</Volume>
            <Issue>2</Issue>
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
            </PubDate>
          </JournalIssue>
          <Title>European journal of clinical microbiology &amp; infectious diseases : official publication of the European Society of Clinical Microbiology</Title>
          <ISOAbbreviation>Eur J Clin Microbiol Infect Dis</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Molecular characterization of Mycoplasma pneumoniae infections in Moscow from 2015 to 2018.</ArticleTitle>
        <Pagination>
          <StartPage>257</StartPage>
          <EndPage>263</EndPage>
          <MedlinePgn>257-263</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1007/s10096-019-03717-6</ELocationID>
        <Abstract>
          <AbstractText>The aim of this study was to assess which Mycoplasma pneumoniae genotypes were present in Moscow during the years 2015-2018 and whether the proportion between detected genotypes changed over time. We were also interested in the presence of macrolide resistance (MR)Mycoplasma pneumoniae. We performed multilocus variable-number tandem-repeat (VNTR) analysis (MLVA), SNP typing, and mutation typing in the 23S rRNA gene from 117 M. pneumoniae clinical isolates. Our analysis suggests two major MLVA types: 4572 and 3562. In 2017-2018, MLVA type 4572 gradually became predominant. In general, the SNP type range is the same as described earlier for European countries. The analysis of MR mutations showed that 7% of the isolates had an A2063G mutation in the 23S rRNA gene with no isolates carrying an A2064G mutation. In 2017-2018, MLVA type 4572 (SNP type 1) begins to spread in Moscow, which was widespread globally, especially in Asian countries. SNP typing of our sample showed higher discriminatory power than MLVA typing.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Voronina</LastName>
            <ForeName>Elena N</ForeName>
            <Initials>EN</Initials>
            <AffiliationInfo>
              <Affiliation>Laboratory of Pharmacogenomics, Institute of Chemical Biology and Fundamental Medicine, Lavrentjeva, 8, Novosibirsk, Russia, 630090. voronina_en@niboch.nsc.ru.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Molecular Biology, Novosibirsk State University, Pirogova, 2, Novosibirsk, Russia, 630090. voronina_en@niboch.nsc.ru.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Gordukova</LastName>
            <ForeName>Maria A</ForeName>
            <Initials>MA</Initials>
            <AffiliationInfo>
              <Affiliation>Moscow City Pediatric G. Speransky Clinical Hospital, No. 9, Shmitovsky Proezd 29, Moscow, Russia, 123317.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Turina</LastName>
            <ForeName>Irina E</ForeName>
            <Initials>IE</Initials>
            <AffiliationInfo>
              <Affiliation>The Federal State Autonomous Educational Institution of Higher Education "The I.M. Sechenov First Moscow State Medical University" of the Ministry of Health of the Russian Federation , Pogodinskaya St. 1, Moscow, Russia, 119991.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Mishukova</LastName>
            <ForeName>Olga V</ForeName>
            <Initials>OV</Initials>
            <AffiliationInfo>
              <Affiliation>Laboratory of Pharmacogenomics, Institute of Chemical Biology and Fundamental Medicine, Lavrentjeva, 8, Novosibirsk, Russia, 630090.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Dymova</LastName>
            <ForeName>Maya A</ForeName>
            <Initials>MA</Initials>
            <AffiliationInfo>
              <Affiliation>Laboratory of Pharmacogenomics, Institute of Chemical Biology and Fundamental Medicine, Lavrentjeva, 8, Novosibirsk, Russia, 630090.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Galeeva</LastName>
            <ForeName>Elena V</ForeName>
            <Initials>EV</Initials>
            <AffiliationInfo>
              <Affiliation>Moscow City Pediatric G. Speransky Clinical Hospital, No. 9, Shmitovsky Proezd 29, Moscow, Russia, 123317.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Korsunskiy</LastName>
            <ForeName>Anatoliy A</ForeName>
            <Initials>AA</Initials>
            <AffiliationInfo>
              <Affiliation>Moscow City Pediatric G. Speransky Clinical Hospital, No. 9, Shmitovsky Proezd 29, Moscow, Russia, 123317.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>The Federal State Autonomous Educational Institution of Higher Education "The I.M. Sechenov First Moscow State Medical University" of the Ministry of Health of the Russian Federation , Pogodinskaya St. 1, Moscow, Russia, 119991.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Filipenko</LastName>
            <ForeName>Maxim L</ForeName>
            <Initials>ML</Initials>
            <AffiliationInfo>
              <Affiliation>Laboratory of Pharmacogenomics, Institute of Chemical Biology and Fundamental Medicine, Lavrentjeva, 8, Novosibirsk, Russia, 630090.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Molecular Biology, Novosibirsk State University, Pirogova, 2, Novosibirsk, Russia, 630090.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016456">Historical Article</PublicationType>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2019</Year>
          <Month>10</Month>
          <Day>27</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>Germany</Country>
        <MedlineTA>Eur J Clin Microbiol Infect Dis</MedlineTA>
        <NlmUniqueID>8804297</NlmUniqueID>
        <ISSNLinking>0934-9723</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D000900">Anti-Bacterial Agents</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D018942">Macrolides</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D012338">RNA, Ribosomal, 23S</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000900" MajorTopicYN="N">Anti-Bacterial Agents</DescriptorName>
          <QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D024881" MajorTopicYN="N">Drug Resistance, Bacterial</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D049674" MajorTopicYN="N">History, 21st Century</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D018942" MajorTopicYN="N">Macrolides</DescriptorName>
          <QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008826" MajorTopicYN="N">Microbial Sensitivity Tests</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D009031" MajorTopicYN="N" Type="Geographic">Moscow</DescriptorName>
          <QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D058885" MajorTopicYN="N">Multilocus Sequence Typing</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D009177" MajorTopicYN="N">Mycoplasma pneumoniae</DescriptorName>
          <QualifierName UI="Q000145" MajorTopicYN="N">classification</QualifierName>
          <QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>
          <QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011019" MajorTopicYN="N">Pneumonia, Mycoplasma</DescriptorName>
          <QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName>
          <QualifierName UI="Q000266" MajorTopicYN="N">history</QualifierName>
          <QualifierName UI="Q000382" MajorTopicYN="Y">microbiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D020641" MajorTopicYN="N">Polymorphism, Single Nucleotide</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D062486" MajorTopicYN="N">Public Health Surveillance</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D012338" MajorTopicYN="N">RNA, Ribosomal, 23S</DescriptorName>
          <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">MLVA</Keyword>
        <Keyword MajorTopicYN="N">Macrolide resistance</Keyword>
        <Keyword MajorTopicYN="N">Mycoplasma pneumoniae</Keyword>
        <Keyword MajorTopicYN="N">SNP</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2019</Year>
          <Month>7</Month>
          <Day>18</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2019</Year>
          <Month>9</Month>
          <Day>20</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2019</Year>
          <Month>10</Month>
          <Day>28</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2020</Year>
          <Month>10</Month>
          <Day>6</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2019</Year>
          <Month>10</Month>
          <Day>28</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">31655931</ArticleId>
        <ArticleId IdType="doi">10.1007/s10096-019-03717-6</ArticleId>
        <ArticleId IdType="pii">10.1007/s10096-019-03717-6</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Rachina SA, Kozlov RS, Shal EP, Ustyuzhanin IV, Krechikov OI, Ivanchik NV et al (2011) A spectrum of causative bacterial pathogens in community-acquired pneumonia in multidisciplinary hospitals of Smolensk. Russ Pulmonol 1:5–18. https://doi.org/10.18093/0869-0189-2011-0-1-5-18</Citation>
        </Reference>
        <Reference>
          <Citation>Dégrange S, Cazanave C, Charron A, Renaudin H, Bébéar C, Bébéar CM (2009) Development of multiple-locus variable-number tandem-repeat analysis for molecular typing of Mycoplasma pneumoniae. J Clin Microbiol 47:914–923. https://doi.org/10.1128/JCM.01935-08</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/JCM.01935-08</ArticleId>
            <ArticleId IdType="pubmed">19204097</ArticleId>
            <ArticleId IdType="pmc">2668363</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Benitez AJ, Diaz MH, Wolff BJ, Pimentel G, Njenga MK, Estevez A et al (2012) Multilocus variable-number tandem-repeat analysis of Mycoplasma pneumoniae clinical isolates from 1962 to the present: a retrospective study. J Clin Microbiol 50:3620–3626. https://doi.org/10.1128/JCM.01755-12</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/JCM.01755-12</ArticleId>
            <ArticleId IdType="pubmed">22952264</ArticleId>
            <ArticleId IdType="pmc">3486201</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sun H, Xue G, Yan C, Li S, Cao L, Yuan Y et al (2013)Multiple-locus variable-number tandem-repeat analysis of mycoplasma pneumoniae Clinical Specimens and Proposal for Amendment of MLVA Nomenclature. PLoS One 8. https://doi.org/10.1371/journal.pone.0064607</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1371/journal.pone.0064607</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Touati A, Blouin Y, Sirand-Pugnet P, Renaudin H, Oishi T, Vergnaud G et al (2015) Molecular epidemiology of mycoplasma pneumoniae: genotyping using single nucleotide polymorphisms and snapshot technology. J Clin Microbiol 53:3182–3194. https://doi.org/10.1128/JCM.01156-15</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/JCM.01156-15</ArticleId>
            <ArticleId IdType="pubmed">26202117</ArticleId>
            <ArticleId IdType="pmc">4572556</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Brown RJ, Holden MTG, Spiller OB, Chalker VJ (2015) Development of a multilocus sequence typing scheme for molecular typing of mycoplasma pneumoniae. J Clin Microbiol 53:3195–3203. https://doi.org/10.1128/JCM.01301-15</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/JCM.01301-15</ArticleId>
            <ArticleId IdType="pubmed">26202118</ArticleId>
            <ArticleId IdType="pmc">4572520</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wolff BJ, Thacker WL, Schwartz SB, Winchell JM (2008) Detection of macrolide resistance in Mycoplasma pneumoniae by real-time PCR and high-resolution melt analysis. Antimicrob Agents Chemother 52:3542–3549. https://doi.org/10.1128/AAC.00582-08</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/AAC.00582-08</ArticleId>
            <ArticleId IdType="pubmed">18644962</ArticleId>
            <ArticleId IdType="pmc">2565909</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chalker VJ, Pereyre S, Dumke R, Winchell J, Khosla P, Sun H et al (2015) International Mycoplasma pneumoniae typing study: interpretation of M pneumoniae multilocus variable-number tandem-repeat analysis. New Microbes New Infect 7:37–40. https://doi.org/10.1016/j.nmni.2015.05.005</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.nmni.2015.05.005</ArticleId>
            <ArticleId IdType="pubmed">26236493</ArticleId>
            <ArticleId IdType="pmc">4501435</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yan C, Sun H, Xue G, Zhao H, Wang L, Feng Y et al (2014) A single-tube multiple-locus variable-number tandem-repeat analysis of Mycoplasma pneumoniae clinical specimens by use of multiplex PCR-capillary electrophoresis. J Clin Microbiol 52:4168–4171. https://doi.org/10.1128/JCM.02178-14</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/JCM.02178-14</ArticleId>
            <ArticleId IdType="pubmed">25232156</ArticleId>
            <ArticleId IdType="pmc">4313281</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Carriço JA, Silva-Costa C, Melo-Cristino J, Pinto FR, de Lencastre H, Almeida JS et al (2006) Illustration of a common framework for relating multiple typing methods by application to macrolide-resistant Streptococcus pyogenes. J Clin Microbiol 44:2524–2532. https://doi.org/10.1128/JCM.02536-05</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/JCM.02536-05</ArticleId>
            <ArticleId IdType="pubmed">16825375</ArticleId>
            <ArticleId IdType="pmc">1489512</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pereyre S, Touati A, Petitjean-Lecherbonnier J, Charron A, Vabret A, Bébéar C (2013) The increased incidence of Mycoplasma pneumoniae in France in 2011 was polyclonal, mainly involving M. pneumoniae type 1 strains. Clin Microbiol Infect 19:2–3. https://doi.org/10.1111/1469-0691.12107</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/1469-0691.12107</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Diaz MH, Benitez AJ, Winchell JM (2015) Investigations of Mycoplasma pneumoniae infections in the United States: trends in molecular typing and macrolide resistance from 2006 to 2013. J Clin Microbiol 53:124–130. https://doi.org/10.1128/JCM.02597-14</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/JCM.02597-14</ArticleId>
            <ArticleId IdType="pubmed">25355769</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ho PL, Law PY, Chan BWK, Wong CW, To KKW, Chiu SS et al (2015) Emergence of macrolide-resistant mycoplasma pneumoniae in Hong Kong is linked to increasing macrolide resistance in multilocus variable-number tandem-repeat analysis type 4-5-7-2. J Clin Microbiol 53:3560–3564. https://doi.org/10.1128/JCM.01983-15</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/JCM.01983-15</ArticleId>
            <ArticleId IdType="pubmed">26338857</ArticleId>
            <ArticleId IdType="pmc">4609705</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Whistler T, Sawatwong P, Diaz MH, Benitez AJ, Wolff BJ, Sapchookul P et al (2017) Molecular characterization of mycoplasma pneumoniae infections in two rural populations of Thailand from 2009 to 2012. J Clin Microbiol 55:2222–2223. https://doi.org/10.1128/JCM.00350-17</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/JCM.00350-17</ArticleId>
            <ArticleId IdType="pubmed">28490485</ArticleId>
            <ArticleId IdType="pmc">5483925</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kogoj R, Praprotnik M, Mrvič T, Korva M, Keše D (2018) Genetic diversity and macrolide resistance of Mycoplasma pneumoniae isolates from two consecutive epidemics in Slovenia. Eur J Clin Microbiol Infect Dis 37:99–107. https://doi.org/10.1007/s10096-017-3106-5</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s10096-017-3106-5</ArticleId>
            <ArticleId IdType="pubmed">28948376</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Suzuki Y, Seto J, Shimotai Y, Itagaki T, Katsushima Y, Katsushima F et al (2017)Multiple-locus variable-number tandem-repeat analysis of mycoplasma pneumoniae isolates between 2004 and 2014 in Yamagata, Japan: Change in molecular characteristics during an 11-year period. Jpn J Infect Dis 70:642–646. https://doi.org/10.7883/yoken.JJID.2017.276</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.7883/yoken.JJID.2017.276</ArticleId>
            <ArticleId IdType="pubmed">29093323</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhao F, Liu G, Cao B, Wu J, Gu Y, He L et al (2013)Multiple-locus variable-number tandem-repeat analysis of 201 mycoplasma pneumoniae isolates from Beijing, China, from 2008 to 2011. J Clin Microbiol 51:636–639. https://doi.org/10.1128/JCM.02567-12</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/JCM.02567-12</ArticleId>
            <ArticleId IdType="pubmed">23224090</ArticleId>
            <ArticleId IdType="pmc">3553874</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Xue G, Li M, Wang N, Zhao J, Wang B, Ren Z et al (2018) Comparison of the molecular characteristics of Mycoplasma pneumoniae from children across different regions of China. PLoS One 13:e0198557. https://doi.org/10.1371/journal.pone.0198557</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1371/journal.pone.0198557</ArticleId>
            <ArticleId IdType="pubmed">30138360</ArticleId>
            <ArticleId IdType="pmc">6107135</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kenri T, Okazaki N, Yamazaki T, Narita M, Izumikawa K, Matsuoka M et al (2008) Genotyping analysis of Mycoplasma pneumoniae clinical strains in Japan between 1995 and 2005: type shift phenomenon of M. pneumoniae clinical strains. J. Med. Microbiol 57:469–475. https://doi.org/10.1099/jmm.0.47634-0</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1099/jmm.0.47634-0</ArticleId>
            <ArticleId IdType="pubmed">18349367</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nilsson AC, Björkman P, Welinder-Olsson C, Widell A, Persson K (2010) Clinical severity of Mycoplasma pneumoniae(MP) infection is associated with bacterial load in oropharyngeal secretions but not with MP genotype. BMC Infect Dis 10:39. https://doi.org/10.1186/1471-2334-10-39</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/1471-2334-10-39</ArticleId>
            <ArticleId IdType="pubmed">20184731</ArticleId>
            <ArticleId IdType="pmc">2837002</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Qu J, Yu X, Liu Y, Yin Y, Gu L, Cao B et al (2013) Specific multilocus variable-number tandem-repeat analysis genotypes of Mycoplasma pneumoniae are associated with diseases severity and macrolide susceptibility. PLoS One 8:8–12. https://doi.org/10.1371/journal.pone.0082174</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1371/journal.pone.0082174</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
